| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |